Phase
Condition
Heart Transplantation
Treatment
OCS Heart System
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
All recipients of heart transplantation with Use of the OCS™ Heart
Exclusion
Exclusion Criteria:
Donor Hearts
Presence of coronary heart diseases
acute myocardial infarction
Presence of heart valve disease (Stenosis or Insufficiency > first degree)
Presence of left ventricular hypertrophy (septum and posterior wall thickness >1.7cm)
State of shock of donor (MAP <60 mmHg, CVP >15, PCWP >15 mmHg) with use ofDobutamine >10 ug/kg/min and/or Norepinephrine > 0.5 ug/kg/min or Epinephrine > 0.2ug/kg/min
irreversible persistant pulmonary hypertrophy, defined as transpulmonary gradient >15 mmHg of the recipient
Study Design
Study Description
Connect with a study center
Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery
Hannover,
GermanySite Not Available
Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery
Hanover 2910831,
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.